Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of E7070 in patients with metastatic melanoma.
Smyth JF, Aamdal S, Awada A, Dittrich C, Caponigro F, Schöffski P, Gore M, Lesimple T, Djurasinovic N, Baron B, Ravic M, Fumoleau P, Punt CJ; EORTC New Drug Development and Melanoma Groups. Smyth JF, et al. Ann Oncol. 2005 Jan;16(1):158-61. doi: 10.1093/annonc/mdi016. Ann Oncol. 2005. PMID: 15598954 Free article. Clinical Trial.
Activity of the dolastatin analogue, LU103793, in malignant melanoma.
Smyth J, Boneterre ME, Schellens J, Calvert H, Greim G, Wanders J, Hanauske A; EORTC Early Clinical Studies Group. Smyth J, et al. Ann Oncol. 2001 Apr;12(4):509-11. doi: 10.1023/a:1011194910571. Ann Oncol. 2001. PMID: 11398885 Free article. Clinical Trial.
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study.
Cameron DA, Cornbleet MC, Mackie RM, Hunter JA, Gore M, Hancock B, Smyth JF; Scottish Melanoma Group. Cameron DA, et al. Among authors: smyth jf. Br J Cancer. 2001 May 4;84(9):1146-9. doi: 10.1054/bjoc.2000.1623. Br J Cancer. 2001. PMID: 11379605 Free PMC article. Clinical Trial.
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE, DeWitte M, Sturgeon C, Propper D, Balkwill FR, Smyth JF. Brown ER, et al. Among authors: smyth jf. Ann Oncol. 2008 Jul;19(7):1340-1346. doi: 10.1093/annonc/mdn054. Epub 2008 Mar 5. Ann Oncol. 2008. PMID: 18325912 Free article. Clinical Trial.
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
Smyth JF, Hardcastle JD, Denton G, Alderson D, Grace RH, Mansi JL, Yosef HM, Nordle O, Lauri H, Wählby S. Smyth JF, et al. Ann Oncol. 1995 Nov;6(9):948-9. doi: 10.1093/oxfordjournals.annonc.a059365. Ann Oncol. 1995. PMID: 8624301 Free article. Clinical Trial. No abstract available.
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report.
Coudert B, Anthoney A, Fiedler W, Droz JP, Dieras V, Borner M, Smyth JF, Morant R, de Vries MJ, Roelvink M, Fumoleau P; European Organization for Research and Treatment of Cancer (EORTC). Coudert B, et al. Among authors: smyth jf. Eur J Cancer. 2001 Nov;37(17):2194-8. doi: 10.1016/s0959-8049(01)00286-6. Eur J Cancer. 2001. PMID: 11677106 Clinical Trial.
287 results